EZH2 and hepatocellular carcinoma: In addition, Jin et al. showed that GHET1 can bind to the enhancer of EZH2 and recruit PRC2 to the promoter region of KLF2; KLF2 acts as a tumor suppressor in hepatocellular carcinoma and is epigenetically repressed [24].